Indirect treatment comparison of oral sebetralstat and intravenous recombinant human C1 esterase inhibitor for on-demand treatment of hereditary angioedema attacks.

Saved in:
Bibliographic Details
Title: Indirect treatment comparison of oral sebetralstat and intravenous recombinant human C1 esterase inhibitor for on-demand treatment of hereditary angioedema attacks.
Authors: Li, H. Henry1 (AUTHOR), Aygören-Pürsün, Emel2 (AUTHOR), Magerl, Markus3,4 (AUTHOR), Craig, Timothy J.5,6 (AUTHOR), Manning, Michael E.7,8 (AUTHOR), Hummel, Noemi9 (AUTHOR), Kopiec, Agnieszka10 (AUTHOR), Fu, Shuai11 (AUTHOR), Morris, James12 (AUTHOR), Wang, Alice13 (AUTHOR), Audhya, Paul K.13 (AUTHOR), Bernstein, Jonathan A.14,15 (AUTHOR) bernstja@ucmail.uc.edu
Source: Allergy, Asthma & Clinical Immunology. 3/15/2025, Vol. 21 Issue 1, p1-11. 11p.
Database: Academic Search Ultimate
Full text is not displayed to guests.
Description
ISSN:17101484
DOI:10.1186/s13223-025-00955-6